Lecture 26 Flashcards
Affect
As a noun, affect refers to feelings or emotions
Just as the primary symptom of schizophrenia is disordered thoughts, affeactive disorders (mood disorders) are charcterized by disordered feelings
Mood (affective)disorder
Serious mood disorder
There are two principal types of mood disorders: bipolar disorder and major depressive disorder
Mood Disorders
Affective disorders are prevalent and dangerous
A diagnosis of depression has a prevalence of approximately 7% in women and 3% in men.
Severely depressed people usually feel unworthy, hopeless, and have strong feelings of guilt
People with mood disorders have a very risk of self-harm and suicide
Bipolar disorder
Serious mood disorder characterized by cyclical periods of mania and depression.
It affects ~1% of the population.
~80% of the risk is attributed to genetics.
Major depressive disorder (MDD)
Serious mood disorder that consists of unremitting depression or periods of depression (that do not alternate with periods of mania).
~40% of the risk is attributed to genetics.
Environmental factors for mood disorders
Environmental factors for mood disorders include traumatic/abusive childhood experiences.
Mania
Episodes of mania are characterized by sense of euphoria that does not seem to be justified by circumstances
People with mania usually exhibit nonstop speech and motor activity
Diagnosis of mania is partly a matter of degree; one would not call exuberance and a zest for life pathological
Lithium
Chemical element
Lithium salts (and anticonvulsants) are commonly prescribed for bipolar disorder
Lithium is most effective for treating the manic phase of bipolar disorder
Once mania is eliminated, depression usually does not follow
Therapeutic effect of lithium is very rapid. The mechanism of action is unknown.
High dose is needed so is not specific to a receptor
Biological treatment for MDD
There are several established and experimental biological treatments for major depressive disorder (MDD)
Drugs that increase serotonin and/or norepinephrine signaling by inhibiting their enzymatic breakdown (e.g., monoamine oxidase inhibitors, MAOi) or by blocking their reuptake (e.g., tricyclics and serotonin specific reuptake inhibitors, SSRIs). Ketamine (NMDA glutamate receptor blocker) Electroconvulsive therapy (ECT) Deep brain stimulation Transcranial magnetic stimulation Vagus nerve stimulation Bright-light therapy (phototherapy) Sleep deprivation
Tricyclic antidepressant
Inhibits reuptake of serotonin and norepinephrine but also affects other neurotransmitters;
Named for the molecular structure
Serotonin specific reuptake inhibitor (SSRI)
A class of drugs that specifically inhibit the reuptake of serotonin without affecting the reuptake of other neurotransmitters.
The most common one is Prozac (fluoxetine).
Similar drugs are Celexa, Paxil, Zoloft, etc…
Serotonin and norepinephrine reuptake inhibitor (SNRI)
Antidepressant drug that specifically inhibits reuptake of norepinephrine and serotonin without affecting reuptake of other neurotransmitters.
Monoamine Hypothesis of Depression
Based largely on the success tricyclic and SSRI treatments, the monoamine hypothesis of depression was developed. The idea is that depression is caused by insufficient monoamine receptor activity (the monoamines are serotonin, norepinephrine, and dopamine).
Because symptoms of depression are generally not relieved by potent dopamine receptor agonists such as amphetamine or cocaine, most investigators have focused their research efforts on the other two monoamines: norepinephrine and serotonin.
Tryptophan is the molecular precursor to serotonin. Giving people a low-tryptophan diet and then a tryptophan-free amino acid “cocktail” lowers brain tryptophan levels and consequently decreases their synthesis of serotonin (5-HT). This tryptophan/serotonin depletion procedure can elicit a depressive episode in people susceptible to depression.
Although SSRIs and SNRIs increase the levels of 5-HT and norepinephrine in the brain very rapidly, the drugs do not relieve symptoms of depression until they have been taken for several weeks
This suggests that something other than a simple increase in monoamine receptor activity is responsible for the normalization of mood
Role of the Frontal Cortex
Functional Imaging Scans
Functional imaging scans have been done on many depressed patients, both before and after a variety of successful treatments.
There are few (if any) correlations. However, the argument has been made that one area of the anterior cingulate cortex (the subgenual region known as area 25) becomes less active after successful treatments.
Deep brain stimulation and transcranial magnetic stimulation
Deep brain stimulation has been tried in the subgenual anterior cingulate cortex as well as in the nucleus accumbens
Other promising approaches involve transcranial magnetic stimulation (TMS) directed to areas of the PFC or vagal nerve stimulation (VNS).
In a small study it worked. In larger ones it usually does not